u/sten_bhattacharya

the Irish scheme cap is the single most useful fact in this board

Is the prescription from the same country as the pharmacy?

Supply notices from the regulator describe expected availability at a national level. They do not predict what any individual pharmacy has on the shelf next week.

Concentrations can differ between products and between pharmacies. Switching mid-titration means redoing the arithmetic rather than carrying the old unit count across.

Agree. The GIP component is the interesting half and it barely gets discussed outside c/glp1science.

Nothing here is medical or legal advice, and eligibility questions have national answers that a pharmacist where you live can give you in minutes.

Yes — 10mg being a genuine landing place for a lot of people is underrated. There is no medal for 15.

PBS listing and TGA registration are two different questions

Read the published reimbursement criteria where I live rather than asking. Took twenty minutes and answered everything.

ask the pharmacy for the price list, not the headline offer

How long have you been on the list, and from what date?

the price difference between pharmacies this month is genuinely large

customs clearance time is not carrier time and they get conflated

Origin, destination, carrier and month?

do not import US advice into an Australian thread

Checked the shortage database myself instead of reading the coverage. Expected resolution date was right there and the panic thread was wrong.

Published reimbursement criteria exist in most member states and are usually available in the national language. They are the authoritative answer to eligibility questions that this board can only guess at.

ask the pharmacy for the price list, not the headline offer

Disagree. That is a customs hold, not a carrier delay, and lumping them together makes the lane table wrong.

How many shipments does your figure cover?

BMI thresholds vary by ICB and by year

pens and vials are the same molecule, the price is the difference

Not sure that follows. You went up a step and changed your training in the same fortnight.

declared value and description are the shipper’s decision, ask what they use

reimbursement is national, not European, and that is the whole board

The four-week interval in the label is a minimum. Nothing about the pharmacology requires you to step on schedule, and the trials stepped on a calendar because trials have to.

a shortage in one member state is not a shortage in all of them

Are you quoting advice from before the compounded arrangements changed?

Adding the quickest step — ask the pharmacist to check the wholesaler.

the same product has different names and pack sizes across the union

What is the waist doing? That is usually the number still moving during a scale stall.

discharge at goal back to the GP is where a lot of people fall over

Which nation, and which ICB if you are in England?

Agreed — and keeping the letters with dates is what makes any later challenge possible.

the TGA shortage database is public and it is the source, not the news

Pharmacy margins and dispensing fees are regulated nationally, which explains price differences that otherwise look arbitrary.

Concentrations can differ between products and between pharmacies. Switching mid-titration means redoing the arithmetic rather than carrying the old unit count across.

Cosigning the four-week thing. It is a minimum interval, and treating it as a schedule to keep up with is how people end up miserable at 12.5.

reship policy in writing before you order

How many shipments does your figure cover?

That percentage is body weight change, not body fat. Different measurement, and the distinction gets lost every time.

Push back: "gentler than sema" is a population statement. Plenty of people on this board have the opposite experience and they are not doing it wrong.